Category Archives: Cancer Knowledge

Lung Cancer: New Genetic Anomalies Discovered

By analyzing the DNA and RNA of lung cancers, researchers at the University of Michigan Comprehensive Cancer Center found that patients whose tumors contained a large number of gene fusions had worse outcomes than patients with fewer gene fusions. Gene fusions are a type of genetic anomaly found in cancers that occurs when genes get rearranged and fuse together. In addition, the researchers identified several new genetic anomalies that occur in lung cancer, including in patients with a history of smoking. …

Light-emitting e-readers before bedtime can adversely impact sleep

“We found the body’s natural circadian rhythms were interrupted by the short-wavelength enriched light, otherwise known as blue light, from these electronic devices,” said Anne-Marie Chang, PhD, corresponding author, and associate neuroscientist in BWH’s Division of Sleep and Circadian Disorders. “Participants reading an LE-eBook took longer to fall asleep and had reduced evening sleepiness, reduced melatonin secretion, later timing of their circadian clock and reduced next-morning alertness than when reading a printed book.” Previous research has shown that blue light suppresses melatonin, impacts the circadian clock and increase alertness, but little was known about the effects of this popular technology on sleep. The use of light emitting devices immediately before bedtime is a concern because of the extremely powerful effect that light has on the body’s natural sleep/wake pattern, and may thereby play a role in perpetuating sleep deficiency…

Vaccine therapy for prostate cancer patients with rising PSA examined — ScienceDaily

As part of a Phase II clinical trial, adult patients with advanced prostate cancer (as evidenced by two rising prostate-specific antigen or PSA values and no visible metastasis) whose cancer is resistant to hormone therapy and had either surgery or radiation were recruited from member institutions in the ECOG-ACRIN Cancer Research Group. In their work, published in the current online edition of European Urology, ECOG-ACRIN investigators examined two different experimental treatment options. In step one, patients were treated with PROSTVAC-V/TRICOM and PROSTVAC-F/TRICOM. PROSTVAC-V is derived from a vaccinia virus that was used for many years to vaccinate against smallpox. …

Tailor-made cancer treatments? New cell culture technique paves the way

The new technique is more than three times as effective as previous methods. Researchers say it’s a major step forward in the study of circulating tumor cells, which are shed from tumors and circulate through the blood of cancer patients. They’re believed to cause metastasis, the spread of cancer through the body that’s responsible for nearly 90 percent of cancer-related deaths. The cells also hold valuable genetic information that could lead doctors to more informed treatment decisions and even tailor-made therapies for individual patients…

Vaccine therapy for prostate cancer patients with rising PSA examined

As part of a Phase II clinical trial, adult patients with advanced prostate cancer (as evidenced by two rising prostate-specific antigen or PSA values and no visible metastasis) whose cancer is resistant to hormone therapy and had either surgery or radiation were recruited from member institutions in the ECOG-ACRIN Cancer Research Group. …

Polymorphism, bacteria inside us help dictate inflammation, antitumor activity

The research reveals a more explicit role about the symbiotic relationship humans have with the various bacteria that inhabit our body and their role during tumor progression. “Our research indicates that interactions between the helpful bacteria in our bodies and immune cells at places situated away from tumors influence systemic responses in the host that alter how these tumors are able to progress,” said Jos� Conejo-Garcia, M.D., Ph.D., Associate Professor and Program Leader in the Tumor Microenvironment and Metastasis Program at The Wistar Institute and lead author of the study…

Latest evidence on using hormone replacement therapy for treating menopausal symptoms

The review highlights that menopausal symptoms, including hot flushes and night sweats are common, affecting around 70% of women for an average of 5 years but may continue for many years in about 10% of women. Every woman experiences the menopause differently; some experience one or two symptoms mildly while others have more severe symptoms. …